Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma [Phase 4]
A Phase 4 trial evaluating the impact of inhaled corticosteroids on intraocular pressure in patients with controlled glaucoma, with complete…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 double-masked trial evaluating PG324 Ophthalmic Solution in open-angle glaucoma and ocular hypertension has completed with results…
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants [Phase 4]
Phase 4 clinical trial update for the XEN implant in moderate primary open angle glaucoma has completed with results posted.
-
FDA approval · 2019-03-22FDA Approved: BIMATOPROST — Original Application (Fosun Pharma USA Inc.)
The FDA approved the original application for bimatoprost, a generic ophthalmic solution manufactured by Fosun Pharma USA Inc., expanding ac…
-
FDA approval · 2019-03-12FDA Approved: ROCKLATAN — Original Application (Alcon Laboratories, Inc.)
The FDA approved ROCKLATAN as an original application for a fixed-dose combination ophthalmic solution of netarsudil 0.02% and latanoprost 0…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-03-11FDA Approved: BRIMONIDINE TARTRATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a generic Brimonidine tartrate ophthalmic product (Original Application) from Somerset Therapeutics, LLC to treat open-angle gl…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product [Phase 2]
Open-label extension study assessing safety of ForSight VISION5 product in Phase 2 for glaucoma conditions; completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert [Phase 2]
Open-label extension to assess safety of the 13 mg bimatoprost ocular insert in patients with primary open-angle glaucoma or ocular hyperten…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery. [NA]
This completed trial evaluated the safety and efficacy of the Hydrus MIGS implant in patients with open-angle glaucoma undergoing cataract s…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG [Phase 1, Phase 2]
The Hydrus Aqueous Implant safety and efficacy study for primary open-angle glaucoma (Phase 1/2) has completed.
-
FDA approval · 2019-01-24FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Leading Pharma, LLC)
FDA approves the original application for dorzolamide hydrochloride as a generic ophthalmic medication indicated for open-angle glaucoma and…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
Clinical trial evaluating a fixed combination ocular insert for open-angle glaucoma or ocular hypertension has completed phases 1 and 2 with…
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 [Phase 3]
Phase 3 trial evaluating CKD-351 for efficacy and safety in primary open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing BOL-303259-X ophthalmic solution to Timolol for open-angle glaucoma or ocular hypertension completed with results po…
-
FDA approval · 2018-11-20FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for bimatoprost from Apotex Corp.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) [Phase 4]
Phase 4 trial updating SIMBRINZA suspension as adjunctive therapy to prostaglandin analogues in open-angle glaucoma or ocular hypertension; …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing BOL-303259-X with timolol in open-angle glaucoma or ocular hypertension has completed with results posted.
-
FDA approval · 2018-10-18FDA Approved: ACETAZOLAMIDE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s Original Application for acetazolamide, confirming a generic version of the drug. The approval allows …
-
FDA approval · 2018-09-12FDA Approved: XELPROS — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves XELPROS (latanoprost) from Sun Pharmaceutical as a new ophthalmic solution for lowering intraocular pressure in open-angle glau…
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 clinical trial evaluating BOL-303259-X with Timolol 0.5% in subjects with open-angle glaucoma or ocular hypertension has completed…
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing safety and efficacy of T-2345 to Xalatan in primary open-angle glaucoma or ocular hypertension completed with posted…
-
FDA approval · 2018-07-16FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb Incorporated, authorizing changes to the pr…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial update evaluating the safety of GANFORT ophthalmic solution in Chinese patients with open-angle glaucoma or ocular hypertensio…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Silicone Tube for the Surgical Treatment of Glaucoma [NA]
A completed clinical trial evaluated a silicone tube device for the surgical treatment of open-angle glaucoma.
-
FDA approval · 2018-06-11FDA Approved: VYZULTA — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for VYZULTA (latanoprostene bunod) submitted by Bausch & Lomb Incorporated.